Last update 01 Nov 2024

Delpacibart zotadirsen

Overview

Basic Info

Drug Type
Antibody oligonucleotide conjugates
Synonyms
Mechanism
DMD exon 44 modulators(Dystrophin exon 44 modulators), TfR1 antagonists(Transferrin receptor protein 1 antagonists)
Inactive Indication-
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
RegulationRare Pediatric Disease (US), Fast Track (US), Orphan Drug (EU)
Login to view timeline

Structure

Molecular FormulaC12H16N2O3
InChIKeyIBLSXJXHUXUHIM-UHFFFAOYSA-N
CAS Registry104676-09-7
Boost your research with our XDC technology data.
Boost your research with our XDC technology data.

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Exon 44 Skipping Mutation Duchenne Muscular DystrophyPhase 2
US
22 Jan 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1/2
-
(bwkkfrbwop) = qfptzjdqpm hlfwccyztz (urpvpfxmoi )
Positive
09 Aug 2024
Phase 1/2
44
(pukkeyranr) = All treatment-emergent adverse events in participants dosed with AOC 1044 were mild to moderate. There were no symptomatic hemoglobin changes, no hypomagnesemia and no renal events. uslswonxlo (vkibazisdx )
Positive
13 Dec 2023
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free